Inflammation, prostaglandins and aspirin-like drugs.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005334:Fever / Q000139:chemically induced; D006099:Granuloma / Q000139:chemically induced; D006801:Humans; D007249:Inflammation; D007275:Injections, Intravenous; D008168:Lung / Q000032:analysis; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D010146:Pain / Q000139:chemically induced; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000096:biosynthesis / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D006899:Mixed Function Oxygenases; D001241:Aspirin